June 9, 2014 — Kalila Medical’s Vado steerable introducer sheath for vascular and intracardiac access, including atrial fibrillation (AF) procedures, has CE mark approval.
Researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI) revealed how a protein encourages the production of stem cells that regenerate damaged tissues of the heart following an acute attack (myocardial infarction). They further assert that it has a better chance of working if provided early in treatment. This was confirmed by molecular imaging, which captured patients’ improved heart health after therapy.
At the 2014 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 7-11, at the St. Louis Convention Center, Siemens Healthcare will debut syngo.via for molecular imaging — a reading solution that transforms large amounts of data into comprehensive results, allowing for organ-based reading [1], reference-based quantification [2] and evidence-based reporting [3] of disease.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT (positron emission tomography/ computed tomography) system enabling both outstanding image quality and intelligent quantitation, helping physicians to deliver the best possible patient outcomes.
Continuing to expand its portfolio of endovascular solutions, Medtronic Inc. announced that two recently U.S. Food and Drug Administration (FDA) approved devices will be featured at the Society for Vascular Surgery’s 2014 Vascular Annual Meeting, taking place June 5-7 in Boston.
Wolters Kluwer Health announced that Kettering Health Network has selected ProVation Order Sets, powered by UpToDate Decision Support, as its clinical content management system.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Among the collection of aspiring medical isotope production companies looking to build facilities in the United States, Coquí RadioPharmaceuticals Corp. is he only one using a design and production method already proven in the commercial markets. Coquí is planning on constructing and operating a dedicated medical isotope production facility.
June 5, 2014 — Fairview Health Services, Minneapolis, recently became the first U.S. healthcare facility to install the Symbia Intevo xSPECT system from Siemens Healthcare. The first ever xSPECT system, the Symbia Intevo fully integrates single-photon emission computed tomography (SPECT) and CT during image reconstruction, combining SPECT’s high sensitivity with the high specificity of CT and completely integrating data from the two modalities to generate high resolution and, for the first time, quantitative images.
June 5, 2014 — Mercator MedSystems is in the midst of its prospective, 300-patient, 30-site DANCE (Dexamethasone to the Adventitia to eNhance Clinical Efficacy) clinical trial to study a new therapeutic approach to treating peripheral artery disease (PAD). The trial enrolled its first patient in November 2013, and incorporates the use of Mercator Med Systems’ U.S. Food and Drug Administration (FDA)-cleared Micro-Infusion drug delivery system.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 5, 2014 — Lumedx Corp. and Scientific Software Solutions Inc. (SSS), maker of PedCath congenital catheterization reporting software, announced they are partnering to create an innovative solution for congenital cardiac data and image management.
June 5, 2014 — The president of the American College of Cardiology (ACC), Patrick O’Gara, M.D., recently explored what is causing the looming interventional cardiologist shortage, how it could threaten the quality of patient care and what can be done about it in the annual Hildner Lecture at the 2014 Society for Cardiovascular Angiography and Interventions (SCAI) scientific sessions.
June 5, 2014 — New measures of the severity of coronary artery blockages do not provide enough accuracy to guide treatment decisions, according to the results of the VERIFY-2 study presented as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2014 scientific sessions in Las Vegas.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Health Media Network (HMN) and the American College of Cardiology (ACC) have announced a strategic partnership that will significantly increase the size of HMN's cardiology network while broadening the distribution of ACC's CardioSmart initiative.
Cook Medical is engaged in two clinical studies that will provide additional data on the safety and effectiveness of inferior vena cava (IVC) filters.
The Accreditation for Cardiovascular Excellence (ACE) Board of Directors has approved a new set of Performance Metrics for Cath PCI Accreditation.